amp.washingtontimes.com Open in urlscan Pro
151.101.66.207  Public Scan

URL: https://amp.washingtontimes.com/news/2009/nov/3/aborted-fetus-cells-used-in-anti-aging-products/
Submission: On December 16 via manual from US — Scanned from DE

Form analysis 0 forms found in the DOM

Text Content

 * Home
 * Politics
 * Culture
 * News
 * Opinion
 * World
 * Security
 * Sports
 * Special Reports
 * My register
 * Letter From The Editor
 * Subscribe

More in Home



ABORTED FETUS CELLS USED IN BEAUTY CREAMS

By Valerie Richardson - The Washington Times - Tuesday, November 3, 2009

A San Francisco cosmetics company has ignited an outcry among pro-lifers for
including an unexpected ingredient in its anti-aging creams: skin-cell proteins
from an aborted fetus.

Children of God for Life, a watchdog group that monitors the use of fetal
material in medical products, called last week for a boycott of all treatments
manufactured by Neocutis Inc., which acknowledges that the key ingredient in its
product line was developed from an aborted boy.

Ad


“There’s just no excuse for using aborted babies in skin-care products,” said
Debi Vinnedge, executive director of Children of God for Life, a 10-year-old
organization based in Murfreesboro, Tenn. “The reaction, the shock and anger
I’ve seen is incredible.”



In a statement released Friday, in response to a wave of condemnation from
pro-life and religious blogs, Neocutis defended the use of its trademarked
ingredient, Processed Skin Cell Proteins, or PSP, arguing that the fetal cell
line was harvested in a responsible, ethical manner for use in treating severe
dermatological injuries.

The company compared its situation to that of researchers who used fetal kidney
cells to develop the polio vaccine.

‌


“Our view - which is shared by most medical professionals and patients - is that
the limited, prudent and responsible use of donated fetal skin tissue can
continue to ease suffering, speed healing, save lives and improve the well-being
of many patients around the globe,” said the statement.

The ingredient was developed at the University of Lausanne in Switzerland from
proteins in the skin tissue of a 14-week-old male baby electively aborted at the
university’s hospital and donated to the Swiss university. The abortion was
deemed medically necessary because the baby could not survive to term, according
to Neocutis.



The fetal skin cell line was taken from a piece of skin the size of a postage
stamp and donated voluntarily by the parents for medical research. The donation
was approved by the hospital’s medical ethics committee and in accordance with
Swiss laws, said the Neocutis statement.

Neocutis also insisted that the one donation would be sufficient for the
manufacture of its products. Critics argue that it’s impossible to know how long
the cell line will last, but Neocutis states on its Web site that “no additional
fetal biopsies will ever be required.”



“We feel we are in complete compliance with the laws of God and the laws of
man,” Neocutis President Mark J. Lemko said in an e-mail response to critics,
which was posted on the Children of God for Life Web site.

Ms. Vinnedge accused the company of playing up PSP’s medical applications in
order to draw attention from its cosmetic uses. Although the company developed
PSP for the treatment of skin ulcers, burns and scarring, Neocutis soon
recognized the ingredient’s value in restoring aging skin.



Neocutis cosmetic products using the cell line include Bio-Restorative Skin
Cream, Bio-Gel Bio-Restorative Hydrogel, Lumiere Bio-Restorative Eye Cream and
Bio-Restorative Serum with PSP Intensive Spot Treatment. In terms of price,
they’re not exactly comparable to Maybelline: A 1-ounce bottle of Journee
Bio-Restorative Day Cream costs $120.

Judie Brown, president of American Life League, said that although use of
aborted fetal parts is indefensible for any purpose, Neocutis’ use for a product
as trivial as an anti-aging cream speaks uniquely to current trends and the
desire for eternal youth.



“What’s new about this is our cultural attitude toward beautification and our
sense of self … and living forever,” she said.

Ms. Vinnedge said she would object to the use of the fetal cell lines no matter
what their use, medical or cosmetic, arguing that mature cells are just as
effective. Indeed, other companies make high-end skin creams using proteins
derived from postnatal placentas, which Mrs. Brown called completely morally
acceptable to pro-lifers.

Even so, Ms. Vinnedge said, using fetal tissue in anti-wrinkle cream crosses
moral and ethical boundaries.



“This is pure vanity,” Ms. Vinnedge said. “We’re talking a medical treatment
versus a vanity treatment.”

She compared it to the Nazis’ use of the skin of Jews to make lampshades. Her
Web site showed a clip from the 1973 science-fiction movie “Soylent Green,” in
which the “secret ingredient” in a popular wafer is found to be human flesh.

The original skin sample may have been tiny, she said, but so is a 14-week
unborn baby. “They say the skin sample was the size of a postage stamp - well,
something that size could mean the whole back,” Ms. Vinnedge said.



Neither the Neocutis Web site nor its advertising makes any secret of the
company’s use of fetal cell lines.

The firm’s online entries say the products were “inspired by fetal skin’s unique
properties” and that the technology “uses cultured fetal skin cells to obtain an
optimal, naturally balanced mixture of skin nutrients.”

“Neocutis means, literally, new skin. And who wouldn’t like to turn back time to
create flawless baby skin again?” says one ad.



Even the company’s critics were surprised by its candor. For years, Ms. Vinnedge
said, she has heard rumors that some beauty companies use aborted fetal cell
lines in their products, but she’s never been able to confirm it because the
Food and Drug Administration doesn’t require the listing of cosmetic
ingredients.

“Usually, when people to write to us about cosmetics, we tell them it’s
impossible to find out,” Ms. Vinnedge said. “That’s why I can’t believe
[Neocutis] posted it.”



Mrs. Brown said the company’s statement struck her as morally and
philosophically unmoored.

“We think the company has taken the position they have because they’re trying to
align themselves with the Catholic identity of some of their founders,” she
said. Neocutis officials “don’t seem to think there’s any complicity on their
part” for using the products of the abortion.

“I think that many companies just say, ‘Is there a good to be achieved,’ and
don’t care how,” she said.



Mrs. Brown said this development isn’t especially surprising to her, recalling
that her group published a book in 1981 called “101 Uses for a Dead Baby,” in
which author Olga Fairfax wrote that fetal tissue could be used for skin care
products and even to grow new limbs.

“Now, we’re more advanced than [Ms. Fairfax] could have imagined,” Mrs. Brown
said.

Ms. Vinnedge’s organization has pushed Congress for years for more detailed
labeling legislation in medicine, but she says she’ll now expand her proposal to
include cosmetics.



“PETA made sure we know that companies aren’t testing cosmetics on animals,” she
said of the animal rights group People for the Ethical Treatment of Animals. “We
want to make sure they’re not using fetal material.”

c Victor Morton contributed to this report.

• Valerie Richardson can be reached at vrichardson@washingtontimes.com.

Copyright © 2022 The Washington Times, LLC. Click here for reprint permission.




 * * 
   * 
   * 
   * 
   * 
 * NEXT ARTICLE

RELATED ARTICLES

 * Reinventing after Globalization
 * The Chiefs Forum: The Next 100 Days
 * Federal Bureau of Investigation
 * Subscriber Only Events
 * Harm Reduction and Public Health








 * Home
 * Politics
 * Culture
 * News
   * All News
   * Politics
   * National
   * World
   * Security
   * Business Economy
   * D.C Local
   * Faith and Family
   * Inside Politics
   * Inside The Beltway
   * Inside The Ring
   * Culture
   * Entertainment
   * Technology
   * Obituaries
   * Just The Headlines
   * Trump Central
   * Campaign 2020
   * Front Page Podcast
   * Photo Galleries
   * Dive Deeper
   * Waste, Fraud & Abuse
   * Media Spotlight
 * Opinion
   * All Opinion
   * Commentary
   * Editorials
   * Letters
   * Pruden On Politics
   * Charles Hurt
   * David Keene
   * Tammy Bruce
   * Ralph Z. Hallow
   * Clifford D. May
   * Cal Thomas
   * Cheryl K. Chumley
   * Joseph Curl
   * Everett Piper
   * Robert Knight
   * Rapid Reactions
   * Tim Constantine
   * Books
   * Cartoons
   * U.S.-Russia Crosstalk
 * World
 * Security
 * Sports
   * All Sports
   * Redskins
   * Football
   * Baseball
   * Basketball
   * NCAA
   * Thom Loverro
   * Deron Snyder
   * Tennis
   * Golf
   * Hockey
   * Soccer
   * Horse Racing
   * Nascar & Racing
 * Special Reports
   * All Special Reports
   * Coronavirus Updates
   * Losing our religion
   * America's Opioid Addiction
   * Infrastructure 2018
   * Rolling Thunder
   * Medicare 2018
   * Free Iran
   * Good Intentions Gone Wrong
   * Agricultural Mixed-Use
 * Podcasts
   * All Podcasts
   * Podcasts Main
   * Front Page Podcasts
   * Politically Unstable
   * Campaign 2020
   * The Right Opinion
   * Bold & Blunt
 * Games
   * All Games
   * Play Sudoku
   * Crossword puzzle
   * Word Search
   * Quizzes
 * Advertising
   * All Advertising
   * Weekly Ads
   * Classified
   * Advertise With Us
   * Ad Payment
 * My register
 * Letter From The Editor
 * Subscribe
 * Sign in
   * All Sign in
   * Today's E-Edition
   * My Account

 * Manage your cookies Do not sell my info

 * 


User Consent Prompt
Focus Prompt

Powered by